Spyre Therapeutics, Inc. (SYRE)

Healthcare · Biotechnology · NASDAQ

Spyre Therapeutics, Inc. (SYRE) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $9.25B and a free-cash-flow yield of -2.5%.

Market cap	$9.25B
Trailing P/E	—
FCF yield	-2.5%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live SYRE data on Nama Insights →